Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy.

NeMoyer RE, Pantin E, Aisner J, Jongco R, Mellender S, Chiricolo A, Moore DF, Langenfeld J.

J Surg Res. 2019 Sep 21;246:19-25. doi: 10.1016/j.jss.2019.07.093. [Epub ahead of print]

PMID:
31550671
2.

Analysis of brain and cerebrospinal fluid from mouse models of the three major forms of neuronal ceroid lipofuscinosis reveals changes in the lysosomal proteome.

Sleat DE, Wiseman JA, El-Banna M, Zheng H, Zhao C, Soherwardy A, Moore DF, Lobel P.

Mol Cell Proteomics. 2019 Sep 9. pii: mcp.RA119.001587. doi: 10.1074/mcp.RA119.001587. [Epub ahead of print]

3.

Glioblastoma and Increased Survival with Longer Chemotherapy Duration.

Jaoude DA, Moore JA, Moore MB, Twumasi-Ankrah P, Ablah E, Moore DF Jr.

Kans J Med. 2019 Aug 21;12(3):65-69. eCollection 2019 Aug.

4.

5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.

Gupta A, Khan AJ, Yegya-Raman N, Sayan M, Ahlawat S, Ohri N, Goyal S, Moore DF, Eladoumikdachi F, Toppmeyer D, Haffty BG.

Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):267-274. doi: 10.1016/j.ijrobp.2019.05.063. Epub 2019 Jun 5.

PMID:
31175905
5.

Increased Morbidity and Mortality of Scleroderma in African Americans Compared to Non-African Americans.

Moore DF, Kramer E, Eltaraboulsi R, Steen VD.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1154-1163. doi: 10.1002/acr.23861. Epub 2019 Aug 7.

PMID:
30821906
6.

Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.

Jang TL, Patel N, Faiena I, Radadia KD, Moore DF, Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y, Kim IY, Lu-Yao GL.

Cancer. 2018 Oct 15;124(20):4010-4022. doi: 10.1002/cncr.31726. Epub 2018 Sep 25.

PMID:
30252932
7.

Solar particle event storm shelter requirements for missions beyond low Earth orbit.

Townsend LW, Adams JH, Blattnig SR, Clowdsley MS, Fry DJ, Jun I, McLeod CD, Minow JI, Moore DF, Norbury JW, Norman RB, Reames DV, Schwadron NA, Semones EJ, Singleterry RC, Slaba TC, Werneth CM, Xapsos MA.

Life Sci Space Res (Amst). 2018 May;17:32-39. doi: 10.1016/j.lssr.2018.02.002. Epub 2018 Feb 21. Review.

PMID:
29753411
8.

Does Certificate of Need Minimize Intensity Modulated Radiation Therapy Use in Patients with Low Risk Prostate Cancer?

Kim S, Patel AN, Nelson C, Shen S, Mayer T, Moore DF, Lu-Yao GL.

Urol Pract. 2016 Sep;3(5):342-348. doi: 10.1016/j.urpr.2015.09.001.

9.

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY; Alliance for Clinical Trials in Oncology and ABTC.

Neuro Oncol. 2018 Mar 27;20(4):546-556. doi: 10.1093/neuonc/nox161.

10.

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.

West HL, Moon J, Wozniak AJ, Mack P, Hirsch FR, Bury MJ, Kwong M, Nguyen DD, Moore DF, Miao J, Redman M, Kelly K, Gandara DR.

Clin Lung Cancer. 2018 Jan;19(1):84-92. doi: 10.1016/j.cllc.2017.06.016. Epub 2017 Jul 6.

11.

Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.

Sleat DE, Tannous A, Sohar I, Wiseman JA, Zheng H, Qian M, Zhao C, Xin W, Barone R, Sims KB, Moore DF, Lobel P.

J Proteome Res. 2017 Oct 6;16(10):3787-3804. doi: 10.1021/acs.jproteome.7b00460. Epub 2017 Aug 28.

12.
13.

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.

Lanthier S, Saposnik G, Lebovic G, Pope K, Selchen D, Moore DF; Canadian Fabry Stroke Screening Initiative Study Group.

Stroke. 2017 Jul;48(7):1766-1772. doi: 10.1161/STROKEAHA.116.016083. Epub 2017 Jun 8.

PMID:
28596458
14.

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.

Jatoi A, Steen PD, Atherton PJ, Moore DF, Rowland KM, Le-Lindqwister NA, Adonizio CS, Jaslowski AJ, Sloan J, Loprinzi C.

Ann Oncol. 2017 Aug 1;28(8):1957-1963. doi: 10.1093/annonc/mdx232.

15.

Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.

Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty BG.

J Clin Oncol. 2017 Jun 20;35(18):2037-2043. doi: 10.1200/JCO.2016.70.7158. Epub 2017 May 1.

16.

A Basic ApoE-Based Peptide Mediator to Deliver Proteins across the Blood-Brain Barrier: Long-Term Efficacy, Toxicity, and Mechanism.

Meng Y, Wiseman JA, Nemtsova Y, Moore DF, Guevarra J, Reuhl K, Banks WA, Daneman R, Sleat DE, Lobel P.

Mol Ther. 2017 Jul 5;25(7):1531-1543. doi: 10.1016/j.ymthe.2017.03.037. Epub 2017 Apr 26.

17.

Chronic Enzyme Replacement to the Brain of a Late Infantile Neuronal Ceroid Lipofuscinosis Mouse Has Differential Effects on Phenotypes of Disease.

Wiseman JA, Meng Y, Nemtsova Y, Matteson PG, Millonig JH, Moore DF, Sleat DE, Lobel P.

Mol Ther Methods Clin Dev. 2017 Feb 13;4:204-212. doi: 10.1016/j.omtm.2017.01.004. eCollection 2017 Mar 17.

18.

Tetrahydrobiopterin deficiency in the pathogenesis of Fabry disease.

Shen JS, Arning E, West ML, Day TS, Chen S, Meng XL, Forni S, McNeill N, Goker-Alpan O, Wang X, Ashcraft P, Moore DF, Cheng SH, Schiffmann R, Bottiglieri T.

Hum Mol Genet. 2017 Mar 15;26(6):1182-1192. doi: 10.1093/hmg/ddx032.

PMID:
28158561
19.

Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study.

Peoples AR, Roscoe JA, Block RC, Heckler CE, Ryan JL, Mustian KM, Janelsins MC, Peppone LJ, Moore DF Jr, Coles C, Hoelzer KL, Morrow GR, Dozier AM.

Support Care Cancer. 2017 Apr;25(4):1271-1278. doi: 10.1007/s00520-016-3520-8. Epub 2016 Dec 20.

20.

Accounting for Protein Subcellular Localization: A Compartmental Map of the Rat Liver Proteome.

Jadot M, Boonen M, Thirion J, Wang N, Xing J, Zhao C, Tannous A, Qian M, Zheng H, Everett JK, Moore DF, Sleat DE, Lobel P.

Mol Cell Proteomics. 2017 Feb;16(2):194-212. doi: 10.1074/mcp.M116.064527. Epub 2016 Dec 6.

21.
22.

Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.

Ahlawat S, Haffty BG, Goyal S, Kearney T, Kirstein L, Chen C, Moore DF, Khan AJ.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):118-125. doi: 10.1016/j.ijrobp.2015.09.011. Epub 2015 Sep 16.

PMID:
26700706
23.

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant.

Malhotra B, Rahal AK, Farhoud H, Moore DF Jr, Kallail KJ.

Case Rep Transplant. 2015;2015:801082. doi: 10.1155/2015/801082. Epub 2015 Nov 25.

24.

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.

Till BG, Li H, Bernstein SH, Fisher RI, Burack WR, Rimsza LM, Floyd JD, DaSilva MA, Moore DF Jr, Pozdnyakova O, Smith SM, LeBlanc M, Friedberg JW.

Br J Haematol. 2016 Jan;172(2):208-18. doi: 10.1111/bjh.13818. Epub 2015 Oct 22.

25.

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

Allegra CJ, Yothers G, O'Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A, Evans LS, Bahary N, Soori G, Eakle JF, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Sharif S, Roh MS, Wolmark N.

J Natl Cancer Inst. 2015 Sep 14;107(11). pii: djv248. doi: 10.1093/jnci/djv248. Print 2015 Nov. Erratum in: J Natl Cancer Inst. 2016 Apr;108(4). pii: djw057. doi: 10.1093/jnci/djw057. Erratum in: J Natl Cancer Inst. 2018 Jul 1;110(7):794.

26.

Small Lymphocytic Lymphoma Presenting with Hypopituitarism.

Moore JA, Moore MB, Samaniego F, Pinnix CC, Moore DF Jr.

Am J Med. 2016 Jan;129(1):e9-e10. doi: 10.1016/j.amjmed.2015.08.016. Epub 2015 Sep 5. No abstract available.

PMID:
26344628
27.

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.

Steensma DP, Dakhil SR, Novotny PJ, Sloan JA, Johnson DB, Anderson DM, Mattar BI, Moore DF Jr, Nikcevich D, Loprinzi CL.

Am J Hematol. 2015 Oct;90(10):877-81. doi: 10.1002/ajh.24110. Epub 2015 Aug 14.

28.

Diagnosis and Treatment of Acute Gout at a University Hospital Emergency Department.

Schlesinger N, Radvanski DC, Young TC, McCoy JV, Eisenstein R, Moore DF.

Open Rheumatol J. 2015 Jun 12;9:21-6. doi: 10.2174/18743129014090100021. eCollection 2015.

29.

Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study.

Lu-Yao GL, Kim S, Moore DF, Shih W, Lin Y, DiPaola RS, Shen S, Zietman A, Yao SL.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):317-24. doi: 10.1038/pcan.2015.30. Epub 2015 Jun 23.

30.

Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.

Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, Moore DF Jr, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG.

J Clin Oncol. 2015 May 20;33(15):1653-9. doi: 10.1200/JCO.2014.58.4508. Epub 2015 Apr 20.

31.

Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.

Lu-Yao GL, Albertsen PC, Moore DF, Lin Y, DiPaola RS, Yao SL.

Eur Urol. 2015 Nov;68(5):805-11. doi: 10.1016/j.eururo.2015.03.021. Epub 2015 Mar 21.

32.

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.

Lucas DM, Ruppert AS, Lozanski G, Dewald GW, Lozanski A, Claus R, Plass C, Flinn IW, Neuberg DS, Paietta EM, Bennett JM, Jelinek DF, Gribben JG, Hussein MA, Appelbaum FR, Larson RA, Moore DF Jr, Tallman MS, Byrd JC, Grever MR.

Leuk Lymphoma. 2015;56(11):3031-7. doi: 10.3109/10428194.2015.1023800. Epub 2015 Mar 30.

33.

Outcome-volume relationships and transhiatal esophagectomy: minimizing "failure to rescue".

Arlow RL, Moore DF, Chen C, Langenfeld J, August DA.

Ann Surg Innov Res. 2014 Dec 19;8(1):9. doi: 10.1186/s13022-014-0009-3. eCollection 2014.

34.

A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.

Blumenthal DT, Rankin C, Stelzer KJ, Spence AM, Sloan AE, Moore DF Jr, Padula GD, Schulman SB, Wade ML, Rushing EJ.

Int J Clin Oncol. 2015 Aug;20(4):650-8. doi: 10.1007/s10147-014-0769-0. Epub 2014 Nov 19.

35.

An animal-to-human scaling law for blast-induced traumatic brain injury risk assessment.

Jean A, Nyein MK, Zheng JQ, Moore DF, Joannopoulos JD, Radovitzky R.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15310-5. doi: 10.1073/pnas.1415743111. Epub 2014 Sep 29.

36.

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL.

JAMA Intern Med. 2014 Sep;174(9):1460-7. doi: 10.1001/jamainternmed.2014.3028.

37.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N.

J Clin Oncol. 2014 Jun 20;32(18):1927-34. doi: 10.1200/JCO.2013.53.7753. Epub 2014 May 5.

38.

Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.

Carpizo DR, Gensure RH, Yu X, Gendel VM, Greene SJ, Moore DF, Jabbour SK, Nosher JL.

J Vasc Interv Radiol. 2014 Feb;25(2):297-306.e1. doi: 10.1016/j.jvir.2013.10.030. Epub 2013 Dec 20.

39.

Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California.

Hudson LO, Reynolds C, Spratt BG, Enright MC, Quan V, Kim D, Hannah P, Mikhail L, Alexander R, Moore DF, Godoy D, Bishop CJ, Huang SS.

J Clin Microbiol. 2013 Nov;51(11):3788-95. doi: 10.1128/JCM.01708-13. Epub 2013 Sep 11.

40.

Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis.

Shao YH, Kim S, Moore DF, Shih W, Lin Y, Stein M, Kim IY, Lu-Yao GL.

Eur Urol. 2014 Apr;65(4):693-700. doi: 10.1016/j.eururo.2013.05.023. Epub 2013 May 21.

41.

Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California.

Hudson LO, Murphy CR, Spratt BG, Enright MC, Elkins K, Nguyen C, Terpstra L, Gombosev A, Kim D, Hannah P, Mikhail L, Alexander R, Moore DF, Huang SS.

PLoS One. 2013 Apr 24;8(4):e62117. doi: 10.1371/journal.pone.0062117. Print 2013.

42.

Hepatitis C and recurrent treatment-resistant acute ischemic stroke.

Saxsena A, Tarsia J, Dunn C, Aysenne A, Shah B, Moore DF.

Proc (Bayl Univ Med Cent). 2013 Apr;26(2):182-4.

43.

Extending the mannose 6-phosphate glycoproteome by high resolution/accuracy mass spectrometry analysis of control and acid phosphatase 5-deficient mice.

Sleat DE, Sun P, Wiseman JA, Huang L, El-Banna M, Zheng H, Moore DF, Lobel P.

Mol Cell Proteomics. 2013 Jul;12(7):1806-17. doi: 10.1074/mcp.M112.026179. Epub 2013 Mar 11.

44.

Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.

Shao YH, Moore DF, Shih W, Lin Y, Jang TL, Lu-Yao GL.

BJU Int. 2013 May;111(5):745-52. doi: 10.1111/j.1464-410X.2012.11758.x. Epub 2013 Jan 17.

45.

Factors controlling variability in nearshore fecal pollution: the effects of mortality.

Rippy MA, Franks PJ, Feddersen F, Guza RT, Moore DF.

Mar Pollut Bull. 2013 Jan 15;66(1-2):191-8. doi: 10.1016/j.marpolbul.2012.09.003. Epub 2012 Nov 21.

46.

Physical dynamics controlling variability in nearshore fecal pollution: fecal indicator bacteria as passive particles.

Rippy MA, Franks PJ, Feddersen F, Guza RT, Moore DF.

Mar Pollut Bull. 2013 Jan 15;66(1-2):151-7. doi: 10.1016/j.marpolbul.2012.09.030. Epub 2012 Nov 19.

47.

Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.

Dubuc V, Moore DF, Gioia LC, Saposnik G, Selchen D, Lanthier S.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1288-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.005. Epub 2012 Nov 17.

PMID:
23168217
48.

Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last?

Kim S, Moore DF, Shih W, Lin Y, Li H, Shao YH, Shen S, Lu-Yao GL.

J Urol. 2013 Jan;189(1):116-21. doi: 10.1016/j.juro.2012.08.091. Epub 2012 Nov 16.

49.

Proteomic analysis of mouse models of Niemann-Pick C disease reveals alterations in the steady-state levels of lysosomal proteins within the brain.

Sleat DE, Wiseman JA, Sohar I, El-Banna M, Zheng H, Moore DF, Lobel P.

Proteomics. 2012 Dec;12(23-24):3499-509. doi: 10.1002/pmic.201200205. Epub 2012 Nov 22.

50.

Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits.

Jabbour SK, Patel S, Herman JM, Wild A, Nagda SN, Altoos T, Tunceroglu A, Azad N, Gearheart S, Moss RA, Poplin E, Levinson LL, Chandra RA, Moore DF, Chen C, Haffty BG, Tuli R.

Int J Surg Oncol. 2012;2012:891067. doi: 10.1155/2012/891067. Epub 2012 Aug 13.

Supplemental Content

Loading ...
Support Center